ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Accelerator Applications
The division was organized to promote the advancement of knowledge of the use of particle accelerator technologies for nuclear and other applications. It focuses on production of neutrons and other particles, utilization of these particles for scientific or industrial purposes, such as the production or destruction of radionuclides significant to energy, medicine, defense or other endeavors, as well as imaging and diagnostics.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Mar 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
April 2025
Nuclear Technology
Fusion Science and Technology
Latest News
State legislation: Illinois bill aims to lift state’s remaining nuclear moratorium
A bill that would fully repeal the state’s entire moratorium on new nuclear projects survived a key deadline in the Illinois General Assembly last week.
To stay afloat in the spring legislative session, bills needed to be assigned to committee by March 21, and state Sen. Sue Rezin’s Senate Bill 1527 now sits with the Senate’s Energy and Public Utilities committee for review.
2024 ANS Annual Conference
Ben Goodrich has spent his career in nuclear-adjacent technology development. As a Director, Ben leads a farrago of business functions including Strategy, Business Development, and Sales within TerraPower Isotopes, an emerging global supplier of actinium-225 used with radioligand therapy for cancer treatments. His expertise includes commercialization, deal structuring and negotiation, financial modeling, clinical trials forecasting, and isotope demand planning.
Ben has enjoyed over a decade of leading technical projects and turning ideas into reality at TerraPower. Prior to TerraPower, Ben worked at Idaho National Laboratory within the Technology Transfer and Commercialization Office.
Ben earned an MBA from Idaho State University and an undergrad from BYU-Idaho. He holds PMP, CVA, and CLP credentials and has multiple patents on hydrocarbon fractionation and liquefaction using super-critical CO2.
Ben currently lives in Northwest Montana with his wife and four children. In his spare time, Ben leads outdoor adventure trips with teenagers and does regular hands-on ‘research’ to find the best trout flies.
Last modified May 30, 2024, 9:12am PDT
